BriaCell Therapeutics (BCTX) Cash & Equivalents (2019 - 2026)
BriaCell Therapeutics' Cash & Equivalents came in at $6.88 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 44.8% from $12.46 million a year earlier and down 77.0% from the prior quarter.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics' Cash & Equivalents was $10.49 million.
- Cash & Equivalents carries a five-year compound annual growth rate of 245.7% (FY2020 to FY2025).
- Going back by fiscal year, Cash & Equivalents was $862,089 in FY2024 (-95.9%), $21.25 million in FY2023 (-48.2%), $41.04 million in FY2022 (-28.3%) and $57.27 million in FY2021.
- The five-year range for quarterly Cash & Equivalents is $862,089 (fiscal Q4 2024) to $57.27 million (fiscal Q4 2021).
- Year-over-year, Cash & Equivalents increased in 1 of the last six quarters, with growth averaging 37.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q2 2026 (growth of 496.4%), and the weakest in fiscal Q3 2024 (a decline of 96.7%).
- Business Quant data shows BCTX's Cash & Equivalents at $29.9 million (Q2 2026), $2.71 million (Q1 2026) and $10.49 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | BriaCell Therapeutics | 31.03 Mn | 30.38 Mn | - | 6.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 6.88 Mn |
| Jan 31, 2026 | 29.90 Mn |
| Oct 31, 2025 | 2.71 Mn |
| Jul 31, 2025 | 10.49 Mn |
| Apr 30, 2025 | 12.46 Mn |
| Jan 31, 2025 | 5.01 Mn |
| Oct 31, 2024 | 5.79 Mn |
| Jul 31, 2024 | 862,089.00 |
| Apr 30, 2024 | 935,694.00 |
| Jan 31, 2024 | 6.24 Mn |
| Oct 31, 2023 | 13.65 Mn |
| Jul 31, 2023 | 21.25 Mn |
| Apr 30, 2023 | 28.17 Mn |
| Jan 31, 2023 | 33.50 Mn |
| Oct 31, 2022 | 37.45 Mn |
| Jul 31, 2022 | 41.04 Mn |
| Apr 30, 2022 | 44.53 Mn |
| Jan 31, 2022 | 47.98 Mn |
| Jul 31, 2021 | 57.27 Mn |
| Apr 30, 2021 | 20.06 Mn |
API Access
BriaCell Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();